Cargando…
New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia
Multiple myeloma (MM) is a malignancy of clonal plasma cells accounting for approximately 10% of haematological malignancies. MM mainly affects older patients, more often males and is more frequently seen in African Americans. The most frequent manifestations of MM are anaemia, osteolytic bone lesio...
Autores principales: | Banaszkiewicz, Małgorzata, Małyszko, Jolanta, Vesole, David H., Woziwodzka, Karolina, Jurczyszyn, Artur, Żórawski, Marcin, Krzanowski, Marcin, Małyszko, Jacek, Batko, Krzysztof, Kuźniewski, Marek, Krzanowska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912471/ https://www.ncbi.nlm.nih.gov/pubmed/31683939 http://dx.doi.org/10.3390/jcm8111828 |
Ejemplares similares
-
New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
por: Woziwodzka, Karolina, et al.
Publicado: (2020) -
Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2020) -
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2022) -
Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
por: Woziwodzka, Karolina, et al.
Publicado: (2021) -
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients
por: Woziwodzka, Karolina, et al.
Publicado: (2021)